FDA Panel Approves Artificial Heart
A U.S. Food and Drug Administration panel votes to back the use of an artificial heart as a temporary device in patients near death who are awaiting a heart transplant. The FDA usually follows the advice of the panel. If approved by the agency, it will be the first artificial heart on the market. NPR's Joe Shapiro reports.
Comments
Discussions for this story are now closed. Please see the Community FAQ for more information.